Lisa brings extensive experience in oncology and CNS drug development to the table. She is especially enthusiastic about the industry’s increasing emphasis on data-driven approaches to deliver impactful results
Lisa brings extensive experience in oncology and CNS drug development to the table. She is especially enthusiastic about the industry’s increasing emphasis on data-driven approaches to deliver impactful results